BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 29449147)

  • 1. Relation between HbA
    Wan EYF; Yu EYT; Fung CSC; Chin WY; Fong DYT; Chan AKC; Lam CLK
    Diabetes Metab; 2018 Nov; 44(5):415-423. PubMed ID: 29449147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations between usual glycated haemoglobin and cardiovascular disease in patients with type 2 diabetes mellitus: A 10-year diabetes cohort study.
    Wan EY; Yu EY; Chen JY; Wong IC; Chan EW; Lam CL
    Diabetes Obes Metab; 2020 Dec; 22(12):2325-2334. PubMed ID: 32744402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do We Need a Patient-Centered Target for Systolic Blood Pressure in Hypertensive Patients With Type 2 Diabetes Mellitus?
    Wan EYF; Yu EYT; Fung CSC; Chin WY; Fong DYT; Chan AKC; Lam CLK
    Hypertension; 2017 Dec; 70(6):1273-1282. PubMed ID: 29038204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New aspects of HbA1c as a risk factor for cardiovascular diseases in type 2 diabetes: an observational study from the Swedish National Diabetes Register (NDR).
    Eeg-Olofsson K; Cederholm J; Nilsson PM; Zethelius B; Svensson AM; Gudbjörnsdóttir S; Eliasson B
    J Intern Med; 2010 Nov; 268(5):471-82. PubMed ID: 20804517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemoglobin glycation index predicts cardiovascular disease in people with type 2 diabetes mellitus: A 10-year longitudinal cohort study.
    Kim MK; Jeong JS; Yun JS; Kwon HS; Baek KH; Song KH; Ahn YB; Ko SH
    J Diabetes Complications; 2018 Oct; 32(10):906-910. PubMed ID: 30121206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes with poor-control HbA1c is cardiovascular disease 'risk equivalent' for mortality: UK Biobank and Hong Kong population-based cohort study.
    Wan EYF; Yu EYT; Mak IL; Youn HM; Chan KS; Chan EWY; Wong ICK; Lam CLK
    BMJ Open Diabetes Res Care; 2023 Jan; 11(1):. PubMed ID: 36634978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of HbA1c and educational level with risk of cardiovascular events in 32,871 drug-treated patients with Type 2 diabetes: a cohort study in primary care.
    Östgren CJ; Sundström J; Svennblad B; Lohm L; Nilsson PM; Johansson G
    Diabet Med; 2013 May; 30(5):e170-7. PubMed ID: 23350893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemoglobin a1c levels and the risk of cardiovascular disease in people without known diabetes: a population-based cohort study in Japan.
    Goto A; Noda M; Matsushita Y; Goto M; Kato M; Isogawa A; Takahashi Y; Kurotani K; Oba S; Nanri A; Mizoue T; Yamagishi K; Yatsuya H; Saito I; Kokubo Y; Sawada N; Inoue M; Iso H; Kadowaki T; Tsugane S;
    Medicine (Baltimore); 2015 May; 94(17):e785. PubMed ID: 25929925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk association of HbA1c variability with chronic kidney disease and cardiovascular disease in type 2 diabetes: prospective analysis of the Hong Kong Diabetes Registry.
    Luk AO; Ma RC; Lau ES; Yang X; Lau WW; Yu LW; Chow FC; Chan JC; So WY
    Diabetes Metab Res Rev; 2013 Jul; 29(5):384-90. PubMed ID: 23463747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shortened Relative Leukocyte Telomere Length Is Associated With Prevalent and Incident Cardiovascular Complications in Type 2 Diabetes: Analysis From the Hong Kong Diabetes Register.
    Cheng F; Luk AO; Tam CHT; Fan B; Wu H; Yang A; Lau ESH; Ng ACW; Lim CKP; Lee HM; Chow E; Kong AP; Keech AC; Joglekar MV; So WY; Jenkins AJ; Chan JCN; Hardikar AA; Ma RCW
    Diabetes Care; 2020 Sep; 43(9):2257-2265. PubMed ID: 32661111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemoglobin A1c variability as an independent correlate of cardiovascular disease in patients with type 2 diabetes: a cross-sectional analysis of the renal insufficiency and cardiovascular events (RIACE) Italian multicenter study.
    Penno G; Solini A; Zoppini G; Orsi E; Fondelli C; Zerbini G; Morano S; Cavalot F; Lamacchia O; Trevisan R; Vedovato M; Pugliese G;
    Cardiovasc Diabetol; 2013 Jul; 12():98. PubMed ID: 23829205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between HbA1c and cardiovascular disease mortality in older Hong Kong Chinese with diabetes.
    Xu L; Chan WM; Hui YF; Lam TH
    Diabet Med; 2012 Mar; 29(3):393-8. PubMed ID: 21916977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of variability in hemoglobin A1c with cardiovascular diseases and mortality in Chinese patients with type 2 diabetes mellitus - A retrospective population-based cohort study.
    Wan EY; Fung CS; Fong DY; Lam CL
    J Diabetes Complications; 2016; 30(7):1240-7. PubMed ID: 27318537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haemoglobin A1c even within non-diabetic level is a predictor of cardiovascular disease in a general Japanese population: the Hisayama Study.
    Ikeda F; Doi Y; Ninomiya T; Hirakawa Y; Mukai N; Hata J; Shikata K; Yoshida D; Matsumoto T; Kitazono T; Kiyohara Y
    Cardiovasc Diabetol; 2013 Nov; 12():164. PubMed ID: 24195452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-specific associations of glycated haemoglobin variability with cardiovascular disease and mortality in patients with type 2 diabetes mellitus: A 10- year cohort study.
    Wan EYF; Yu EYT; Chin WY; Ng FTY; Chia SMC; Wong ICK; Chan EWY; Lam CLK
    Diabetes Obes Metab; 2020 Aug; 22(8):1316-1327. PubMed ID: 32196917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Individualized homeopathic treatment in addition to conventional treatment in type II diabetic patients in Hong Kong - a retrospective cohort study.
    To KLA; Fok YYY; Chong KCM; Lee YCJ; Yiu LSS
    Homeopathy; 2017 May; 106(2):79-86. PubMed ID: 28552177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic control and cardiovascular risk factors in type 2 diabetes mellitus patients according to diabetes duration.
    Franch-Nadal J; Roura-Olmeda P; Benito-Badorrey B; Rodriguez-Poncelas A; Coll-de-Tuero G; Mata-Cases M;
    Fam Pract; 2015 Feb; 32(1):27-34. PubMed ID: 25194144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and predictors for cardiovascular disease in Chinese patients with type 2 diabetes mellitus - a population-based retrospective cohort study.
    Wan EY; Fong DY; Fung CS; Lam CL
    J Diabetes Complications; 2016 Apr; 30(3):444-50. PubMed ID: 26774791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of baseline risk on the relation between HbA1c and risk for new cardiovascular events and mortality in patients with type 2 diabetes and symptomatic cardiovascular disease.
    Bots SH; van der Graaf Y; Nathoe HM; de Borst GJ; Kappelle JL; Visseren FL; Westerink J;
    Cardiovasc Diabetol; 2016 Jul; 15(1):101. PubMed ID: 27431507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obesity, clinical, and genetic predictors for glycemic progression in Chinese patients with type 2 diabetes: A cohort study using the Hong Kong Diabetes Register and Hong Kong Diabetes Biobank.
    Jiang G; Luk AO; Tam CHT; Lau ES; Ozaki R; Chow EYK; Kong APS; Lim CKP; Lee KF; Siu SC; Hui G; Tsang CC; Lau KP; Leung JYY; Tsang MW; Kam G; Lau IT; Li JK; Yeung VT; Lau E; Lo S; Fung SKS; Cheng YL; Chow CC; Pearson ER; So WY; Chan JCN; Ma RCW; ;
    PLoS Med; 2020 Jul; 17(7):e1003209. PubMed ID: 32722720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.